Iovance Biotherapeutics Inc. buy Robert W. Baird
Start price
28.02.25
/
50%
€3.77
Target price
28.02.26
€19.21
Performance (%)
-44.41%
Price
18.12.25
€2.09
Summary
This prediction is currently active. The BUY prediction by Robert_W__Baird for Iovance Biotherapeutics Inc. is performing very badly with a performance of -44.41%. This prediction currently runs until 28.02.26. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Iovance Biotherapeutics Inc. | 9.534% | 9.534% |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by Robert_W__Baird for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Robert W. Baird from $24.00 to $20.00. They now have an "outperform" rating on the stock.
Ratings data for IOVA provided by MarketBeat